Madrigal Pharmaceuticals Inc.
MDGL | NASDAQ
$524.50
+$2.54 (+0.49%)
Sep 22, 2026, 12:33 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -45.32 | -14.09 | -11.57 | -16.85 | -5.79 | -8.49 |
PEG Ratio | 1.10 | -1.47 | -0.72 | -0.95 | -0.49 | -0.05 |
PS Ratio | 13.63 | 36.44 | n/a | n/a | n/a | n/a |
PB Ratio | 21.68 | 8.70 | 10.67 | 25.20 | 7.15 | 7.16 |
P/FCF Ratio | -68.75 | -14.36 | -13.28 | -22.10 | -7.61 | -10.88 |
P/OCF Ratio | -68.92 | -14.41 | -13.34 | -22.12 | -7.62 | -10.90 |
OCF/S Ratio | -19.78 | -252.91 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.59 | 0.16 | 0.29 | 0.25 | 0 | 0 |
Quick Ratio | 3.77 | 5.90 | 5.38 | 3.12 | 3.54 | 6.13 |
Current Ratio | 4.01 | 6.10 | 5.38 | 3.12 | 3.54 | 6.13 |
Asset Turnover | 0.76 | 0.17 | n/a | n/a | n/a | n/a |
Interest Coverage | -13.45 | -33.94 | -29.93 | -74.06 | n/a | n/a |
Return on Equity | -47.83% | -61.76% | -92.18% | -149.63% | -123.32% | -84.28% |
Return on Assets | -22.89% | -44.70% | -58.33% | -81.46% | -88.48% | -70.47% |
Return on Invested Capital | -31.58% | -56.97% | -72.82% | -118.72% | -123.15% | -85.70% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 94.14% | 96.54% | n/a | n/a | n/a | n/a |
Net Profit Margin | -30.08% | -258.64% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -30.08% | -258.64% | n/a | n/a | n/a | n/a |
Operating Profit Margin | -31.31% | -276.39% | n/a | n/a | n/a | n/a |
FCF Margin | -19.83% | -253.72% | n/a | n/a | n/a | n/a |
EBITDA Margin | -27.59% | -249.88% | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MDGL